|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Benazepril#Patient Counseling Information]] |
| {{Benazepril}}
| |
| {{CMG}} ; {{AE}} {{AM}}
| |
| | |
| ==Patient Counseling Information==
| |
| | |
| ====Information for Patients====
| |
| | |
| <u>'''Pregnancy'''</u>: Female patients of childbearing age should be told about the consequences of exposure to Lotensin during [[pregnancy]]. Discuss treatment options with women planning to become pregnant. Patients should be asked to report pregnancies to their physicians as soon as possible.
| |
| | |
| <u>'''Angioedema'''</u>: [[Angioedema]], including [[laryngeal edema]], can occur at any time with treatment with [[ACE inhibitors]]. Patients should be so advised and told to report immediately any signs or symptoms suggesting [[angioedema]] (swelling of face, eyes, lips, or tongue, or difficulty in breathing) and to take no more drug until they have consulted with the prescribing physician.
| |
| | |
| <u>'''Symptomatic Hypotension'''</u>: Patients should be cautioned that [[lightheadedness]] can occur, especially during the first days of therapy, and it should be reported to the prescribing physician. Patients should be told that if [[syncope occurs]], Lotensin should be discontinued until the prescribing physician has been consulted.
| |
| | |
| All patients should be cautioned that inadequate fluid intake or excessive [[perspiration]], [[diarrhea]], or [[vomiting]] can lead to an excessive fall in [[blood pressure]], with the same consequences of [[lightheadedness]] and possible [[syncope]].
| |
| | |
| <u>'''Hyperkalemia'''</u>: Patients should be told not to use [[potassium]] supplements or salt substitutes containing potassium without consulting the prescribing physician.
| |
| | |
| <u>'''Neutropenia'''</u>: Patients should be told to promptly report any indication of [[infection]] (e.g., [[sore throat]], [[fever]]), which could be a sign of [[neutropenia]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LOTENSIN (BENAZEPRIL HYDROCHLORIDE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4d954024-a191-46e3-ba71-2a7d5b0c65d5#nlm34067-9 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |